NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
about
The retinoid X receptors and their ligandsRegulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sitesSulindac-Derived RXRα Modulators Inhibit Cancer Cell Growth by Binding to a Novel SiteAdvances in drug design with RXR modulatorsPrediction of drug-target interactions and drug repositioning via network-based inferencePraziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growthNew aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cellsTranscriptional and Non-Transcriptional Functions of PPARβ/δ in Non-Small Cell Lung Cancer.Identification of a New RXRα Antagonist Targeting the Coregulator-Binding Site.AEG-1 regulates retinoid X receptor and inhibits retinoid signaling.Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alphaPharmacological protection of retinal pigmented epithelial cells by sulindac involves PPAR-α.Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB.Inhibition of β-catenin signaling by nongenomic action of orphan nuclear receptor Nur77Serine 350 of human pregnane X receptor is crucial for its heterodimerization with retinoid X receptor alpha and transactivation of target genes in vitro and in vivoNSC-640358 acts as RXRα ligand to promote TNFα-mediated apoptosis of cancer cellTargeting truncated RXRα for cancer therapy.Liver X receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localization.Targeting truncated retinoid X receptor-α by CF31 induces TNF-α-dependent apoptosis.A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagyRegulation of proteolytic cleavage of retinoid X receptor-α by GSK-3βNew use for an old drug: COX-independent anti-inflammatory effects of sulindac in models of cystic fibrosis.Synthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation.Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis.Systematic dissection of dysregulated transcription factor-miRNA feed-forward loops across tumor types.RXRα ligand Z-10 induces PML-RARα cleavage and APL cell apoptosis through disrupting PML-RARα/RXRα complex in a cAMP-independent mannerCOX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.NSAIDs inhibit tumorigenesis, but how?Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.Direct Modulation of Small GTPase Activity and Function.Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα.Targeting to the non-genomic activity of retinoic acid receptor-gamma by acacetin in hepatocellular carcinomaModulation of the Nur77-Bcl-2 apoptotic pathway by p38α MAPK.Novel hybrids of drug with bioactive heterocycles for enhancing biological activity.Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells.Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy.Retinoid acid receptor expression is helpful to distinguish between adenoma and well-differentiated carcinoma in the thyroid.Retinoid X Receptor AntagonistsOverview of the structure-based non-genomic effects of the nuclear receptor RXRα
P2860
Q24562747-D2D43950-8767-4A28-8DE9-BC7D35CD76EAQ27025972-139C26A6-729A-42A9-A95C-E61D28CC88E8Q27682952-7AF65418-EEF3-43DE-AA2E-1E135393CC21Q28274388-4B9A5F87-80B7-41DE-B685-25EF0BB357FCQ28483634-D67F40B1-CCA0-4F87-ABD5-E376F2EF83DAQ28484303-7EFBA03A-8E8C-413E-B02D-A57408EB505DQ28534587-EEEB0BCC-272F-4E7B-9C69-36D0D8924AB2Q31103456-5D3EA597-DCE6-4767-8DD7-3DE673DFFED8Q33889103-F676C97D-A925-4661-96D8-59F4210B7047Q34055706-55EA2BF9-4BE3-42B4-965E-4480081667E8Q34251206-A1159622-0EDB-4EBE-B188-BC2E52257653Q34601724-E8047520-BFCB-4BF1-B84F-7F5280E9EBCEQ35612396-F5D0E856-A7B1-430D-9150-6C9CE3AB36DDQ35670308-D2EE9127-24C5-4722-80D0-AD7711A281C5Q35920690-E56CC1C8-67B9-488C-B7C0-E349BB1B7318Q35956818-648B7F7E-9803-461B-B465-A0758F402646Q36398740-C2D5014B-8594-43E8-A00B-1CA885D6B5E9Q36413574-5DE1CD17-6EB7-428F-85E0-D1644CD41183Q36510879-AA7CD90A-027F-4E70-9B54-5E1A9917F324Q36836915-FF88FDC4-938B-4042-82DC-CDC96361BD56Q36895372-C3D4729C-3085-4CC1-BBCB-F84118897565Q36903409-4B98B2BF-1CAF-4DFD-9F48-39FAE2F1A90EQ37082125-0653E930-5D02-4378-A7C7-612DEF0A379BQ37191199-752AA1A6-AC5A-4996-AB5F-A2A804B82EF9Q37480571-BE0AC107-0758-4FCE-8657-0F1C9A8AA1EDQ37707093-CFEE7727-79F7-488F-BF9D-9A638D37F636Q38123175-7036D22A-8A0E-46E8-8E73-F7A8E1D4B409Q38169133-EE77C17C-9436-4CBA-B00B-FF41C6A1E9F3Q38379632-8FF61769-1828-4A87-9C0C-E211F99CC668Q38608107-472A5B5E-374A-46E6-AE71-1A8B1E3B9BFDQ41077880-0965219C-91F1-4A85-904E-B3FC91684E28Q42274085-D9014718-5229-46D1-9E82-E0F9A8F818FBQ42378374-FF4AA217-B36E-4868-8396-4D58E5592C69Q46367131-FF91CA58-C9C9-4FA9-9D3A-76CAE8CC31AAQ47152429-F118C233-103D-41A9-A152-4C26EDD4C442Q50199467-D07D3778-E633-4DF2-850E-8DAECE544412Q51022828-E2105496-9EEA-4A28-A0E7-6D86F6B5BA79Q58789337-9CB3CE1C-357C-438B-881E-F0EB6D27F20DQ58798014-4879120E-D278-42EB-83D5-52D94E8B01A7
P2860
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@ast
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@en
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@en-gb
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@nl
type
label
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@ast
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@en
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@en-gb
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@nl
prefLabel
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@ast
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@en
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@en-gb
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@nl
P2093
P2860
P1433
P1476
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
@en
P2093
Andrei Molotkov
Bingzhen Lin
Fuquan Jiang
Hai-Ping Zhang
Jiebo Chen
Jin-Zhang Zeng
Jinghua Yu
P2860
P304
P356
10.1016/J.CCR.2010.04.023
P407
P577
2010-06-15T00:00:00Z